TOP｜ 特許｜ 意匠｜ 商標
商標ウォッチ Twitter
公開日2025-04-16
公報種別公開国際商標公報
国際登録番号1838822
国際登録日2024-08-14
区分第5類(薬剤),第42類(科学・技術)
商品役務Pharmaceutical preparations for the prevention and treatment of diseases and disorders related to the immune system, autoimmune diseases and disorders, cancer, oncology indications, or hematologic disorders; protein-based therapeutics for the treatment of diseases and disorders related to the immune system, autoimmune diseases and disorders, cancer, oncology indications, or hematologic disorders; therapeutic and preventative vaccines; medical, biological and pharmaceutical preparations containing polypeptide encoding nucleic acids for the prevention and treatment of diseases and disorders; RNA-based therapeutics; therapeutic agents for the treatment of diseases and disorders related to the immune system, autoimmune diseases and disorders, cancer, oncology indications, or hematologic disorders.,Research and development in the biotechnology field; consulting services in the fields of biotechnology and genetic science; development of new technology for others in the fields of genomics and biotechnology; providing laboratory research services in the field of gene expression or RNA-based therapeutics; testing, inspection, research, or development of chemical and biotechnology preparations; scientific research in the fields of pharmaceuticals全 34 件を表示, vaccines, medicine, biologics, biotherapeutics, biosimilars and therapeutics; design, engineering, research, development and testing services in the field of protein-encoding nucleic acids and polypeptide-encoding nucleic acids; providing information on the subject of scientific and medical research in the fields of biotechnology, biologics, biosimilars, pharmaceuticals, vaccines, and therapeutics related to genetic science, genomics, gene expression, protein-encoding nucleic acids or polypeptide-encoding nucleic acids.
基礎出願番号98597164
基礎出願日2024-06-12
基礎出願国US
出願人Orbital Therapeutics, Inc.
OCRテキストTHERAPEUTICS
OCRテキスト2
OCRについて
この商標をJ-PlatPatで参照する

関連商標

Mylan Inc.
1か月前
F. Hoffmann-La Roche AG
IKRASKO
4日前
GentiBio, Inc.
1日前
Zomedica Corp.
1日前
Samyang Holdings Corporation
1日前
Soho Flordis International Pty Ltd
1日前
Natmedics GmbH
1日前
HansolBio
1日前
Lycored Ltd.
1日前
BEIJING INNO MEDICINE CO., LTD.
1日前
Shanghai Qianzhi Care Products Co., Ltd.
1日前
European Foundation for the care of newborn infants (EFCNI)
1日前
Dong-A Pharmaceutical Co., Ltd.
1日前
OCuSOFT INC.
OUST
4日前
Stratpharma AG
COLSIGEN
4日前
Annexon, Inc.
1日前
NODCURE INC.
nBiome
4日前
CENTARIX BIOTECH LTD.
Centa
4日前
METAVIA INC.
METAVIA
4日前
Shenzhen Wandao Cell Technology Co., Ltd.
WonderCel THERAPEUTICS
4日前
MR. KARAN AGRAWAL, MR. LALIT AGRAWAL, MR.GHANSHYAM KUMAR ALL ARE PARTNERS OF Om Shiva Products Inc.
VITO
4日前
F. Hoffmann-La Roche AG
REMRASGY
4日前
FAMILLE MICHAUD APICULTEURS
BEELIZ
4日前
Developing Countries Vaccine Manufactures Network
Developing Countries Vaccine 8 InternationalManufacturers
4日前
Developing Countries Vaccine Manufactures Network
4日前
Developing Countries Vaccine Manufactures Network
DCVMN INTERNATIONAL DevelopingCountriesVaccine ManufacturersNetworkInternational WECONNECTTOPROTECT!
4日前
F. Hoffmann-La Roche AG
SUNFENVO
4日前
F. Hoffmann-La Roche AG
IMRASGO
4日前
Telix Pharmaceuticals Limited
PROLUMINAR
4日前
Glaxo Group Limited
1日前
Annexon, Inc.
1日前
F. Hoffmann-La Roche AG
VYVHALI
4日前
Onikoroshi, LLC
1日前
Hangzhou Yubai Biotechnology Co., Ltd.
vetwish
今日
Kagome Australia Pty Ltd
NinjinFibre
今日
Cohesys Inc.
cohesys
今日
続きを見る